Plasma N-glycome shows continuous deterioration as the diagnosis of insulin resistance approaches

Ana Cvetko, Massimo Mangino, Marko Tijardović, Domagoj Kifer, Mario Falchi, Toma Keser, Markus Perola, Tim D. Spector, Gordan Lauc, Cristina Menni, Olga Gornik*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)


Introduction Prediction of type 2 diabetes mellitus (T2DM) and its preceding factors, such as insulin resistance (IR), is of great importance as it may allow delay or prevention of onset of the disease. Plasma protein N-glycome has emerged as a promising predictive biomarker. In a prospective longitudinal study, we included patients with a first diagnosis of impaired glucose metabolism (IR or T2DM) to investigate the N-glycosylation's predictive value years before diabetes development. Research design and methods Plasma protein N-glycome was profiled by hydrophilic interaction ultra-performance liquid chromatography in 534 TwinsUK participants free from disease at baseline. This included 89 participants with incident diagnosis of IR or T2DM during the follow-up period (7.14±3.04 years) whose last sample prior to diagnosis was compared using general linear regression with 445 age-matched unrelated controls. Findings were replicated in an independent cohort. Changes in N-glycome have also been presented in connection with time to diagnosis. Results Eight groups of plasma N-glycans were different between incident IR or T2DM cases and controls (p<0.05) after adjusting for multiple testing using Benjamini-Hochberg correction. These differences were noticeable up to 10 years prior to diagnosis and are changing continuously as becoming more expressed toward the diagnosis. The prediction model was built using significant glycan traits, displaying a discriminative performance with an area under the receiver operating characteristic curve of 0.77. Conclusions In addition to previous studies, we showed the diagnostic potential of plasma N-glycome in the prediction of both IR and T2DM development years before the clinical manifestation and indicated the continuous deterioration of N-glycome toward the diagnosis.

Original languageEnglish
Article numbere002263
JournalBMJ Open Diabetes Research and Care
Issue number1
Publication statusPublished - 13 Sept 2021


  • diabetes mellitus
  • glycosylation
  • insulin resistance
  • preventive medicine
  • type 2


Dive into the research topics of 'Plasma N-glycome shows continuous deterioration as the diagnosis of insulin resistance approaches'. Together they form a unique fingerprint.

Cite this